Bach Ardalan
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 51
- Colorectal Cancer Treatments and Studies 31
- Pancreatic and Hepatic Oncology Research 12
- Cancer Treatment and Pharmacology 11
-
- Biochemical and Molecular Research 17
- Cancer therapeutics and mechanisms 9
- Co-authors
- Pochi R. Subbarayan (13 shared papers)Robert I. Glazer (3 shared papers)Howard Silberman (2 shared papers)Alan S. Livingstone (17 shared papers)Hiremagalur N. Jayaram (11 shared papers)Thomas R. Fleming (3 shared papers)David A. Cooney (9 shared papers)Cathy Tangen (1 shared paper)
- Journals
- Journal of Clinical Oncology (15 papers)Cancer (6 papers)Biochemical Pharmacology (4 papers)Investigational New Drugs (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Bach Ardalan
99 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 98
- Oncology 1.1k
- Hepatology 114
- Pathology and Forensic Medicine 181
- Cancer Research 143
- Pulmonary and Respiratory Medicine 301
Countries citing papers authored by Bach Ardalan
This map shows the geographic impact of Bach Ardalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bach Ardalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bach Ardalan more than expected).
Fields of papers citing papers by Bach Ardalan
This network shows the impact of papers produced by Bach Ardalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bach Ardalan. The network helps show where Bach Ardalan may publish in the future.
Co-authors
The 25 scholars most cited alongside Bach Ardalan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 288 | |
| 2 | 1991 | 161 | |
| 3 | 1988 | 115 | |
| 4 | Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil. | 1980 | 66 |
| 5 | 1981 | 64 | |
| 6 | Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits. | 1981 | 56 |
| 7 | Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival. | 1999 | 54 |
| 8 | 2014 | 49 | |
| 9 | Reduction of daunorubicin lethality and myocardial cellular alterations by pretreatment with ICRF-187 in Syrian golden hamsters. | 1979 | 48 |
| 10 | 1978 | 46 | |
| 11 | 2010 | 41 | |
| 12 | 1977 | 39 | |
| 13 | 1981 | 37 | |
| 14 | 2010 | 36 | |
| 15 | 2006 | 36 | |
| 16 | Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics. | 1988 | 36 |
| 17 | 1998 | 34 | |
| 18 | Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU. | 2010 | 28 |
| 19 | Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid. | 1981 | 28 |
| 20 | 1999 | 25 |
About Bach Ardalan
Bach Ardalan is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 104 papers that have together received 2.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (31 papers), Biochemical and Molecular Research (17 papers), Pancreatic and Hepatic Oncology Research (12 papers), Cancer Treatment and Pharmacology (11 papers), Gastric Cancer Management and Outcomes (9 papers), Esophageal Cancer Research and Treatment (9 papers), Cancer therapeutics and mechanisms (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). The work is most often cited by research in Oncology (1.1k citations), Hepatology (114 citations), Pathology and Forensic Medicine (181 citations), Cancer Research (143 citations) and Pulmonary and Respiratory Medicine (301 citations). Bach Ardalan has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Pochi R. Subbarayan, Robert I. Glazer, Howard Silberman, Alan S. Livingstone, Hiremagalur N. Jayaram, Thomas R. Fleming, David A. Cooney, Cathy Tangen, Pasquale Benedetto and James H. Doroshow. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Biochemical Pharmacology, Investigational New Drugs and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.